This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, C Articles by Burch, J B Search for Related Content PubMed PubMed Citation Articles by Liu, C Articles by Burch, J B

 Previous Article  |  Next Article 

J Virol. 1994 April; 68(4): 2286-2296

Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations.

Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.

ABSTRACT

Hepatitis B viruses (hepadnaviruses) can cause chronic, productive infections of hepatocytes. Analyses of the enhancers and promoters of these viruses in cell lines have suggested a requirement of these elements for liver-enriched transcription factors. In this study, a minimum of seven factor-binding sites on the duck hepatitis B virus enhancer were detected by DNase I footprinting using duck liver nuclear extracts. Among the sites that were tentatively identified were one C/EBP-, one HNF1-, and two HNF3-binding sites. Mutations of the HNF1- and HNF3-like sites, which eliminated factor binding, as assessed by both DNase I footprinting and competitive gel shift assays, were evaluated for their effects on enhancer activity. Using a construct in which human growth hormone was expressed from the viral enhancer and core gene promoter, we found that all of the mutations, either alone or in combination, reduced expression two- to fourfold in LMH chicken hepatoma cells. The mutations in the HNF1 site and one of the HNF3 sites, when inserted into the intact viral genome, also suppressed virus RNA synthesis in primary hepatocyte cultures. Virus carrying the latter HNF3 mutation was also examined for its ability to infect and replicate in ducks. No significant inhibition of virus replication was observed in a short-term assay; however, virus with the HNF3 mutation was apparently unable to grow in the pancreas, a second site of duck hepatitis B virus replication in the duck.

This article has been cited by other articles:

• Zimmerman, K. A., Fischer, K. P., Joyce, M. A., Tyrrell, D. L. J. (2008). Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture. J. Virol. 82: 8013-8021 [Abstract] [Full Text]  
• Guo, H., Mason, W. S., Aldrich, C. E., Saputelli, J. R., Miller, D. S., Jilbert, A. R., Newbold, J. E. (2005). Identification and Characterization of Avihepadnaviruses Isolated from Exotic Anseriformes Maintained in Captivity. J. Virol. 79: 2729-2742 [Abstract] [Full Text]  
• Tang, H., McLachlan, A. (2002). Avian and Mammalian Hepadnaviruses Have Distinct Transcription Factor Requirements for Viral Replication. J. Virol. 76: 7468-7472 [Abstract] [Full Text]  
• Seeger, C., Mason, W. S. (2000). Hepatitis B Virus Biology. Microbiol. Mol. Biol. Rev. 64: 51-68 [Abstract] [Full Text]  
• Wei, Y., Tennant, B., Ganem, D. (1998). In Vivo Effects of Mutations in Woodchuck Hepatitis Virus Enhancer II. J. Virol. 72: 6608-6613 [Abstract] [Full Text]